Patients with both inv(16)/t(16;16) AML/ TET2 mut and inv(16)/t(16;16) AML/ FLT3-ITD mut also had higher WBC counts than those with t(8;21) AML/ TET2 mut and t(8;21) AML/ FLT3-ITD mut , but these differences did not reach statistical significance (p=0.088 and 0.067, respectively).
← all excerpts
Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with <i>RUNX1-RUNX1T1</i> or <i>CBFB-MYH11</i> Fusions
1
0.0880
0.0880